These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1983509)

  • 41. [Quality requirements in clinical studies in surgery exemplified by prevention of thromboembolism].
    Rödiger H; Nowak W; Kneist W
    Zentralbl Chir; 1991; 116(12):757-60. PubMed ID: 1656653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of undesirable effects of low-molecular-weight heparin during prevention of thromboembolic disease in abdominal surgery patients].
    Morales-Polanco MR; Sigler-Morales L; Meillón-García LA; Romero-Hernández T; Blanco-Benavides R
    Gac Med Mex; 1997; 133(6):541-6. PubMed ID: 9504084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
    Baumgartner A; Jacot N; Moser G; Krähenbühl B
    Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep venous thrombosis--a meta-analysis].
    Nielsen JD; Landorph A
    Ugeskr Laeger; 1994 Oct; 156(40):5844-9. PubMed ID: 7985276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.
    Boneu B
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
    Welzel D; Wolf H; Koppenhagen K
    Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug prevention of thromboembolism in elective hip surgery with reference to thrombophilic conditions].
    Liedloff H; Brauckhoff KF
    Z Gesamte Inn Med; 1989 Jun; 44(11):320-3. PubMed ID: 2669388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
    Bergqvist D
    Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prevention of thromboembolic disease in gynecologic surgery].
    Urlep-Salinović V; Jelatancev B
    Jugosl Ginekol Perinatol; 1990; 30(1-2):35-7. PubMed ID: 2214851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
    Marbet GA
    Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D; Hirsh J; Heit J; Prins M; Davidson B; Lensing AW
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Significance of drug prevention of thromboembolism in urologic risk patients].
    Schulz B; Winter P; Heinrichs C
    Z Urol Nephrol; 1987 Jan; 80(1):37-42. PubMed ID: 2437732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of thromboembolism complications with low molecular weight heparin in microneurosurgical lumbar intervertebral disk operations].
    Prestar FJ
    Neurochirurgia (Stuttg); 1992 Jan; 35(1):1-4. PubMed ID: 1314965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.
    Voth D; Schwarz M; Hahn K; Dei-Anang K; al Butmeh S; Wolf H
    Neurosurg Rev; 1992; 15(4):289-94. PubMed ID: 1336131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboprophylactic effect of low molecular weight heparin started in the evening before elective general abdominal surgery: a comparison with low-dose heparin.
    Bergqvist D; Burmark US; Frisell J; Guilbaud O; Hallböök T; Horn A; Lindhagen A; Ljungner H; Ljungström KG; Mätzsch T
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():19-24. PubMed ID: 1962900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
    Weber U; Koppenhagen K; Mälzer H; Matthes M
    Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. II: Reduced dose of low molecular weight heparin.
    Borstad E; Urdal K; Handeland G; Abildgaard U
    Acta Obstet Gynecol Scand; 1992 Aug; 71(6):471-5. PubMed ID: 1326846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.